Widespread Myofascial Dysfunction and Sensitisation in Women with Endometriosis-associated Chronic Pelvic Pain: A Cross-sectional Study
Overview
Neurology
Psychiatry
Authors
Affiliations
Background: Chronic pelvic pain persists in some women with endometriosis even after lesion removal and optimized hormonal treatment.
Objective: Characterize the presence and distribution of pain, myofascial dysfunction and sensitisation beyond the pelvis in women with endometriosis-associated chronic pelvic pain.
Methods: Cross-sectional study of 30 women prior to participation in a clinical trial. Evaluation included pain-focused abdominopelvic gynaecologic examination with the identification of pelvic floor muscle spasm. Neuro-musculoskeletal examination assessed paraspinal allodynia and hyperalgesia bilaterally and myofascial trigger points in 13 paired muscles. Pressure-pain thresholds were measured over interspinous ligaments and trigger points. Women completed the body territories element of the Body Pain Index.
Results: All women had a pelvic floor muscle spasm that they self-identified as a major focus of pain. Twenty of 30 women described their pelvic pain as focal. However, all demonstrated widespread myofascial dysfunction with low pressure-pain thresholds and trigger points in over two-thirds of 26 assessed regions. Widespread spinal segmental sensitisation was present in 17/30, thoracic in 21/30 and lumbosacral/pelvic in 18/30. Cervical sensitisation manifested as low pressure-pain thresholds with 23/30 also reporting recurrent, severe headaches and 21/30 experiencing orofacial pain. Those reporting diffuse pelvic pain were more likely to have widespread (p = .024) and lumbosacral/pelvic (p = .036) sensitisation and report over 10 painful body areas (p = .009).
Conclusions: Women with endometriosis-associated chronic pelvic pain often have myofascial dysfunction and sensitisation beyond the pelvic region that may be initiated or maintained by on-going pelvic floor spasm. These myofascial and nervous system manifestations warrant consideration when managing pain in this population. Clinicaltrials.gov identifier: NCT01553201.
Significance: Women with endometriosis often have pelvic pain persisting after surgery despite hormonal therapies and these women have regional pelvic sensitisation and myofascial dysfunction. Pelvic floor muscle spasm is a major pain focus in this population. Sensitisation and myofascial dysfunction are widespread, beyond the pelvic region. On-going pelvic floor spasm may initiate or maintain sensitisation. Myofascial/sensitisation manifestations warrant consideration when managing pain in this population.
Harvey M, Shi M, Oh Y, Mitchell D, Slayden O, MacLean 2nd J bioRxiv. 2025; .
PMID: 39896574 PMC: 11785222. DOI: 10.1101/2025.01.23.634555.
Nociplastic Pain in Endometriosis: A Scoping Review.
Gentles A, Goodwin E, Bedaiwy Y, Marshall N, Yong P J Clin Med. 2025; 13(24).
PMID: 39768444 PMC: 11727753. DOI: 10.3390/jcm13247521.
Mick I, Freger S, van Keizerswaard J, Gholiof M, Leonardi M Ther Adv Reprod Health. 2024; 18:26334941241277759.
PMID: 39376635 PMC: 11457249. DOI: 10.1177/26334941241277759.
Sandrieser L, Heine J, Bekos C, Perricos-Hess A, Wenzl R, Husslein H J Clin Med. 2024; 13(16).
PMID: 39200746 PMC: 11354640. DOI: 10.3390/jcm13164604.
Zhu M, Huang F, Xu J, Chen W, Ding B, Shen Y Heliyon. 2024; 10(14):e34534.
PMID: 39156584 PMC: 11330104. DOI: 10.1016/j.heliyon.2024.e34534.